Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up-Reference-Cited by-同舟云学术

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

Published:2011-02 Issue:2 Volume:22 Page:452-457
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Penel N.,Le Cesne A.,Bui B.N.,Perol D.,Brain E.G.,Ray-Coquard I.,Guillemet C.,Chevreau C.,Cupissol D.,Chabaud S.,Jimenez M.,Duffaud F.,Piperno-Neumann S.,Mignot L.,Blay J.-Y.

Funder

Novartis SA

Conticanet

European Society for Medical Oncology

French National Cancer Institut

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/2/452/404560/mdq341.pdf

Reference26 articles.

1. Desmoid tumours;Biermann;Curr Treat Options Oncol,2000

2. Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases;Penel;Sarcoma,2008

3. Follow up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas, and epidermal cysts;Gardner;Am J Hum Genet,1962

4. The desmoid tumor: not a benign disease;Posner;Arch Surg,1989

5. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a pediatric oncology group phase II trial;Shapek;J Clin Oncol,2007

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor;European Journal of Cancer;2024-09

2. Function-preserving surgery in sporadic desmoid-type fibromatosis of brachial plexus;The National Medical Journal of India;2024-06-17

3. Diagnosis and Management of Desmoid Fibromatosis of the Breast;World Journal of Oncology;2024-06

4. Desmoid tumor of brachial plexus manifesting as neck asymmetry – a case study;Polski Przegląd Otorynolaryngologiczny;2024-05-22

5. Efficacy and safety of anlotinib in patients with desmoid fibromatosis: a retrospective analysis;Frontiers in Oncology;2024-05-14